2021 annual financial data
BioNTech 2021 Operating cash flow margin
BioNTech 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was 4.69%.
Operating income was 15,283,800,000 EUR and net income was 10,292,500,000 EUR.
Operating cash flow was 889,700,000 EUR.
Get free BioNTech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,976,700,000 EUR
- Operating income
- 15,283,800,000 EUR
- Net income
- 10,292,500,000 EUR
- Operating cash flow
- 889,700,000 EUR